Scandinavian ChemoTech

Scandinavian ChemoTech's Animal Care is pleased to announce a recent sale of its vetIQure™ TSE device with treatment kits to veterinary practice Christoph Sonntag in Germany specializing in the care of domestic animals, with a focus on dogs and cats. This latest partnership further establishes our commitment to providing high-quality solutions to animal healthcare providers in Europe.

"We're excited to support the evolving needs of veterinary clinics in Germany that are dedicated to the health and well-being of pets," said Mohan Frick, CEO. "This sale is a testament to the trust veterinarians place in our products to enhance patient care and outcomes. We look forward to fostering a lasting relationship with Dr Sonntag."

For further information please contact:

Mohan Frick, CEO

Phone: +46 (0)10-218 93 00

E-mail: ir@chemotech.se

Scandinavian ChemoTech AB (publ)

ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer patients access to a new treatment alternative, Tumour Specific Electroporation™ (TSE), available for treatment of both humans and animals. There are a large number of cancer patients whose tumours for various reasons cannot be treated by conventional methods but where TSE can be a solution. Therefore, the company continuously evaluates new opportunities and areas of application for the technology. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Redeye AB is the company's Certified Adviser. Read more at: www.chemotech.se.